Detection of lipocortin 1 in human lung lavage fluid: lipocortin degradation as a possible proteolytic mechanism in the control of inflammatory mediators and inflammation.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 1568329)

Published in Environ Health Perspect on April 01, 1990

Authors

S F Smith1, T D Tetley, A Guz, R J Flower

Author Affiliations

1: Department of Medicine, Charing Cross and Westminster Medical School, London, UK.

Articles citing this

Annexin-A1: a pivotal regulator of the innate and adaptive immune systems. Br J Pharmacol (2008) 1.43

Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression. Am J Pathol (2001) 1.37

Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc Natl Acad Sci U S A (1992) 1.34

Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc Natl Acad Sci U S A (1995) 1.24

Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3. J Biol Chem (2007) 1.10

Glucocorticoid-induced annexin 1 secretion by monocytes and peritoneal leukocytes. Br J Pharmacol (1995) 0.96

Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer (2004) 0.94

Annexin A1 and the Resolution of Inflammation: Modulation of Neutrophil Recruitment, Apoptosis, and Clearance. J Immunol Res (2016) 0.83

Two dimensional protein patterns of bronchoalveolar lavage fluid from non-smokers, smokers, and subjects exposed to asbestos. Thorax (1996) 0.83

The role of lipocortin-1 in dexamethasone-induced suppression of PGE2 and TNF alpha release from human peripheral blood mononuclear cells. Br J Pharmacol (1996) 0.83

Cathepsin G-regulated release of formyl peptide receptor agonists modulate neutrophil effector functions. J Biol Chem (2012) 0.81

Annexin 1 localisation in tissue eosinophils as detected by electron microscopy. Mediators Inflamm (2002) 0.81

Implications of tyrosine phosphoproteomics in cervical carcinogenesis. J Carcinog (2008) 0.81

Lipocortin 1: glucocorticoids caught in the act? Thorax (1996) 0.78

Reduction of nitric oxide release from alveolar macrophages by a lipocortin peptide. Mediators Inflamm (1998) 0.75

Effect of dexamethasone on carrageenin-induced inflammation in the lung. Mediators Inflamm (1995) 0.75

Inflammatory neutrophils secrete annexin 1 during experimentally induced colitis in rats. Dig Dis Sci (1999) 0.75

Articles cited by this

Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91

Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature (1986) 4.57

Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids. J Biol Chem (1987) 2.75

Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site. J Biol Chem (1979) 2.66

Mouse macrophage elastase. Purification and characterization as a metalloproteinase. Biochem J (1981) 2.38

The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation. J Biol Chem (1981) 2.08

Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J Infect Dis (1984) 2.02

Purification and partial sequence analysis of a 37-kDa protein that inhibits phospholipase A2 activity from rat peritoneal exudates. J Biol Chem (1986) 1.66

Extracellular elastolytic activity in human lung lavage: a comparative study between smokers and non-smokers. Clin Sci (Lond) (1985) 1.35

Background and discovery of lipocortins. Agents Actions (1986) 1.04

The presence of lipocortin in human embryonic skin fibroblasts and its regulation by anti-inflammatory steroids. Biochim Biophys Acta (1985) 1.01

Cigarette smoking, lung inflammation, and the development of emphysema. J Lab Clin Med (1988) 0.96

Purification and characterization of proteolytic fragments of lipocortin I that inhibit phospholipase A2. J Biol Chem (1987) 0.96

Effects of cigarette smoking and drugs on respiratory tract proteases and antiproteases. Eur J Respir Dis Suppl (1987) 0.93

Enzymatic activities of bronchoalveolar lavages in coal workers pneumoconiosis. Lung (1983) 0.90

Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids. J Immunol (1986) 0.87

Purification of three forms of lipocortin from bovine lung. Cell Calcium (1987) 0.87

Inhibition of leukocyte chemotaxis by Glu-Glu-Glu-Glu-Tyr-Pro-Met-Glu and Leu-Ile-Glu-Asp-Asn-Glu-Tyr-Thr-Ala-Arg-Gln-Gly. Biochem Biophys Res Commun (1984) 0.86

Specificity and inhibition of glucocorticoid-induced macrocortin secretion from rat peritoneal macrophages. Br J Pharmacol (1983) 0.86

Lipocortin output by human endometrium in vitro. J Clin Endocrinol Metab (1986) 0.83

Dexamethasone inhibits respiratory glycoconjugate secretion from feline airways in vitro by the induction of lipocortin (lipomodulin) synthesis. Am Rev Respir Dis (1988) 0.82

Articles by these authors

Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev (1974) 7.76

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A (1993) 4.82

Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins (1976) 4.44

Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature (1979) 4.41

Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature (1980) 4.29

The importance of phospholipase-A2 in prostaglandin biosynthesis. Biochem Pharmacol (1976) 3.88

Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature (1972) 3.30

A new approach to anti-inflammatory drugs. Biochem Pharmacol (1979) 2.95

Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation, and inhibition by anti-inflammatory steroids. Br J Pharmacol (1978) 2.41

Quantitative determination of prostaglandins and malondialdehyde formed by the arachidonate oxygenase (prostaglandin synthetase) system of bovine seminal vesicle. Prostaglandins (1973) 2.39

Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur Respir J (1989) 2.04

Diazepam in the treatment of dyspnoea in the 'Pink Puffer' syndrome. Q J Med (1980) 2.01

Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol (1999) 1.99

Evidence for reflex upper airway dilator muscle activation by sudden negative airway pressure in man. J Physiol (1991) 1.98

Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat Med (1996) 1.96

Anti-phospholipase proteins. Prostaglandins (1984) 1.93

Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet (1990) 1.88

The distribution and metabolism of arachidonic acid in rabbit platelets during aggregation and its modification by drugs. Br J Pharmacol (1977) 1.87

Regional cerebral blood flow during volitional breathing in man. J Physiol (1991) 1.84

Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. Proc Natl Acad Sci U S A (1989) 1.82

Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. Br J Pharmacol (1982) 1.74

Inflammatory effects of prostaglandin D2 in rat and human skin. Br J Pharmacol (1976) 1.69

Afferent pathway(s) for pharyngeal dilator reflex to negative pressure in man: a study using upper airway anaesthesia. J Physiol (1991) 1.66

The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods (1980) 1.66

Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids. Nature (1976) 1.65

Lipopolysaccharide, tumor necrosis factor, and interleukin-1 interact to cause hypotension. J Lab Clin Med (1992) 1.65

Inhibition of phospholipase. Br Med Bull (1983) 1.65

Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung. Nature (1987) 1.63

Observations of renal function in patients undergoing therapeutic diuresis with frusemide. Clin Sci (1970) 1.61

Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc Natl Acad Sci U S A (1998) 1.60

Motor cortical representation of the diaphragm in man. J Physiol (1991) 1.60

Controlled trial of respiratory health worker visiting patients with chronic respiratory disability. Br Med J (Clin Res Ed) (1987) 1.59

Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br J Pharmacol (2000) 1.57

Synthesis of 6-keto-PGF1alpha by ram seminal vesicle microsomes. Prostaglandins (1977) 1.57

Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J Immunol (1993) 1.57

The role of vagal and glossopharyngeal afferent nerves in respiratory sensation, control of breathing and arterial pressure regulation in conscious man. Clin Sci (1966) 1.55

The measurement of breathlessness induced in normal subjects: validity of two scaling techniques. Clin Sci (Lond) (1985) 1.53

Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1. Br J Pharmacol (1997) 1.50

Pharyngeal size and shape during wakefulness and sleep in patients with obstructive sleep apnoea. Q J Med (1989) 1.49

Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model. J Leukoc Biol (1998) 1.49

Rapid reduction of prostaglandin 15-hydroxy dehydrogenase activity in rat tissues after treatment with protein synthesis inhibitors. Br J Pharmacol (1975) 1.48

Changes in global cerebral blood flow in humans: effect on regional cerebral blood flow during a neural activation task. J Physiol (1993) 1.48

Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects. J Exp Med (1997) 1.47

Carbon monoxide in alveolar air as an index of exposure to cigarette smoke. Clin Sci Mol Med (1976) 1.47

Unilateral focal lesions in the rostrolateral medulla influence chemosensitivity and breathing measured during wakefulness, sleep, and exercise. J Neurol Neurosurg Psychiatry (1999) 1.45

Regional cerebral blood flow during volitional expiration in man: a comparison with volitional inspiration. J Physiol (1993) 1.44

Annexin-A1: a pivotal regulator of the innate and adaptive immune systems. Br J Pharmacol (2008) 1.43

Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolism. Nature (1976) 1.41

Synchronization of motor unit firing during different respiratory and postural tasks in human sternocleidomastoid muscle. J Physiol (1989) 1.41

Cigarette smoking among secondary schoolchildren in 1975. Prevalence of respiratory symptoms, knowledge of health hazards, and attitudes to smoking and health. J Epidemiol Community Health (1978) 1.41

Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody. J Immunol (1993) 1.40

Studies of the pulmonary vagal control of central respiratory rhythm in the absence of breathing movements. J Physiol (1973) 1.40

Stroke volume in conscious dogs; effect of respiration, posture, and vascular occlusion. J Appl Physiol (1965) 1.40

1-phenyl-3-pyrazolidone: an inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets. Prostaglandins (1978) 1.39

Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes. Biochim Biophys Acta (1978) 1.37

Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression. Am J Pathol (2001) 1.37

The effect of anaesthesia of the airway in dog and man: a study of respiratory reflexes, sensations and lung mechanics. Clin Sci Mol Med (1976) 1.36

A self paced treadmill walking test for breathless patients. Thorax (1985) 1.36

Extracellular elastolytic activity in human lung lavage: a comparative study between smokers and non-smokers. Clin Sci (Lond) (1985) 1.35

The inhibition by hydrocortisone of prostaglandin biosynthesis in rat peritoneal leucocytes is correlated with intracellular macrocortin levels. Br J Pharmacol (1981) 1.34

Inhibition of prostaglandin biosynthesis. Biochem Pharmacol (1974) 1.34

The effect of sleep on reflex genioglossus muscle activation by stimuli of negative airway pressure in humans. J Physiol (1994) 1.34

Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc Natl Acad Sci U S A (1992) 1.34

Arterial oxygen saturation and breathlessness in patients with chronic obstructive airways disease. Clin Sci (Lond) (1987) 1.32

Sympathetic and parasympathetic cardiac control in athletes and nonathletes at rest. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.32

Is the voluntary control of exercise in man necessary for the ventilatory response? J Physiol (1984) 1.32

The role of non-myelinated vagal afferent fibres from the lungs in the genesis of tachypnoea in the rabbit. J Physiol (1971) 1.31

A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats. Br J Pharmacol (1986) 1.31

Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule. Involvement of endogenous lipocortin 1. J Immunol (1995) 1.30

Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins. Eur J Pharmacol (1984) 1.28

Breathlessness and psychiatric morbidity in chronic bronchitis and emphysema: a study of psychotherapeutic management. Psychol Med (1983) 1.28

The effect of varying tidal volume on the associated phrenic motoneurone output:studies of vagal and chemical feedback. Respir Physiol (1975) 1.28

Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery in vitro. Prostaglandins (1987) 1.28

The effect of airway anaesthesia on the control of breathing and the sensation of breathlessness in man. Clin Sci (Lond) (1985) 1.27

Hydrocortisone and 'macrocortin' inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes. Life Sci (1985) 1.27

Inspiratory coactivation of the genioglossus enlarges retroglossal space in laryngectomized humans. J Appl Physiol (1985) (1996) 1.26

The effect of bilateral block of vagus and glossopharyngeal nerves on the ventilatory response to CO2 of conscious man. Respir Physiol (1966) 1.26

Arachidonic acid 15-lipoxygenase from rabbit peritoneal polymorphonuclear leukocytes. Partial purification and properties. J Biol Chem (1981) 1.25

Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc Natl Acad Sci U S A (1995) 1.24

The role of spinal cord transmission in the ventilatory response to exercise in man. J Physiol (1984) 1.24

Putative cerebral cortical involvement in the ventilatory response to inhaled CO2 in conscious man. J Physiol (1990) 1.23

Validation of beat by beat pulsed Doppler measurements of ascending aortic blood velocity in man. Cardiovasc Res (1987) 1.23

Search for evidence of lung chemoreflexes in man: study of respiratory and circulatory effects of phenyldiguanide and lobeline. Clin Sci (1972) 1.22

The effect of carbon dioxide in the airways and alveoli on ventilation; a vagal reflex studied in the dog. J Physiol (1974) 1.22

Arterial oxygen desaturation during treadmill and bicycle exercise in patients with chronic obstructive airways disease. Clin Sci (Lond) (1985) 1.22

Blood pressure and flow in the ascending aorta of conscious dogs. Cardiovasc Res (1967) 1.22

Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. FASEB J (2006) 1.21

Identification of higher brain centres that may encode the cardiorespiratory response to exercise in humans. J Physiol (2001) 1.21

The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. Am Rev Respir Dis (1991) 1.21

Effects of modulators of arachidonic acid metabolism on the synthesis and release of slow-reacting substance of anaphylaxis. Br J Pharmacol (1979) 1.21

Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. Cell Growth Differ (1998) 1.20

POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. J Immunol (1999) 1.20

Glucocorticoid-and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo. Br J Pharmacol (1993) 1.19

Annexin I is stored within gelatinase granules of human neutrophil and mobilized on the cell surface upon adhesion but not phagocytosis. Cell Biol Int (2000) 1.17

The assay of endogenous cholecystokinin and factors influencing its release in the dog and cat. Gastroenterology (1971) 1.17

Mast cells in the human alveolar wall: an electronmicroscopic study. J Clin Pathol (1981) 1.16

Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action. FASEB J (2001) 1.16

Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone. Br J Pharmacol (1997) 1.15

Identification of several species of phospholipase inhibitory protein(s) by radioimmunoassay for lipomodulin. Biochem Biophys Res Commun (1982) 1.15